Numiera Therapeutics
Translational Oncology and Metabolic Therapeutics Development
Numiera Therapeutics, Timnath, Colorado, us, 80547
Overview
Numiera Therapeutics, founded in 2023 and headquartered in Denver, Colorado, is a biotechnology company developing small-molecule therapies that target cancer cell metabolism. The company focuses on glioblastoma, a highly aggressive brain cancer, using approaches that inhibit fatty acid oxidation to disrupt tumor growth and progression. Job Summary
Numiera Therapeutics is seeking a Senior Scientist – Translational Oncology and Metabolic Therapeutics Development to lead advanced preclinical research projects. The successful candidate will design, execute, and interpret experiments exploring metabolic pathways in cancer, collaborate with cross-functional teams, and help translate preclinical findings into therapeutic candidates for clinical development. Responsibilities
Lead preclinical research programs targeting cancer metabolism and metabolic vulnerabilities. Design and implement in vitro and in vivo experiments to evaluate therapeutic efficacy. Analyze complex data sets, prepare reports, and communicate findings to internal teams. Collaborate with medicinal chemistry, pharmacology, and clinical development teams to integrate research into drug development pipelines. Contribute to patent filings, scientific publications, and presentations for regulatory submissions. Mentor junior scientists and support team development initiatives. Qualifications
PhD in Cancer Biology, Molecular Biology, Biochemistry, or related field. Minimum 5 years of postdoctoral or industry experience in oncology or metabolism research. Expertise in metabolic assays, molecular biology, preclinical models, and data analysis. Strong leadership, project management, and communication skills. Demonstrated ability to work collaboratively in multidisciplinary teams. Preferred Qualifications
Experience with translational drug discovery and preclinical development pipelines. Peer-reviewed publications in oncology or cancer metabolism. Knowledge of regulatory requirements for preclinical studies. Benefits
Competitive salary with performance incentives. Health, dental, and vision insurance. Retirement savings plan with company match. Paid time off, holidays, and professional development opportunities. Collaborative, innovative, and growth-oriented work environment.
#J-18808-Ljbffr
Numiera Therapeutics, founded in 2023 and headquartered in Denver, Colorado, is a biotechnology company developing small-molecule therapies that target cancer cell metabolism. The company focuses on glioblastoma, a highly aggressive brain cancer, using approaches that inhibit fatty acid oxidation to disrupt tumor growth and progression. Job Summary
Numiera Therapeutics is seeking a Senior Scientist – Translational Oncology and Metabolic Therapeutics Development to lead advanced preclinical research projects. The successful candidate will design, execute, and interpret experiments exploring metabolic pathways in cancer, collaborate with cross-functional teams, and help translate preclinical findings into therapeutic candidates for clinical development. Responsibilities
Lead preclinical research programs targeting cancer metabolism and metabolic vulnerabilities. Design and implement in vitro and in vivo experiments to evaluate therapeutic efficacy. Analyze complex data sets, prepare reports, and communicate findings to internal teams. Collaborate with medicinal chemistry, pharmacology, and clinical development teams to integrate research into drug development pipelines. Contribute to patent filings, scientific publications, and presentations for regulatory submissions. Mentor junior scientists and support team development initiatives. Qualifications
PhD in Cancer Biology, Molecular Biology, Biochemistry, or related field. Minimum 5 years of postdoctoral or industry experience in oncology or metabolism research. Expertise in metabolic assays, molecular biology, preclinical models, and data analysis. Strong leadership, project management, and communication skills. Demonstrated ability to work collaboratively in multidisciplinary teams. Preferred Qualifications
Experience with translational drug discovery and preclinical development pipelines. Peer-reviewed publications in oncology or cancer metabolism. Knowledge of regulatory requirements for preclinical studies. Benefits
Competitive salary with performance incentives. Health, dental, and vision insurance. Retirement savings plan with company match. Paid time off, holidays, and professional development opportunities. Collaborative, innovative, and growth-oriented work environment.
#J-18808-Ljbffr